How A Patent Attorney Became A Biopharma CEO In The Middle Of COVID-19
Source: Life Science Leader
In this executive virtual roundtable (EVR) component, Ivana Magovcevic-Liebisch, Ph.D., J.D., CEO of Vigil Neuroscience, a microglia-focused therapeutics company, shares how her biopharma career progressed from patent attorney to CEO, the important role played by networking, and the experience of coming in during the middle of COVID-19.
View the full presentation here.
This website uses cookies to ensure you get the best experience on our website. Learn more